CoChat

3β-Hydroxysteroid Dehydrogenase/Δ5→4-Isomerase Activity Associated with the Human 17β-Hydroxysteroid Dehydrogenase Type 2 Isoform1

Suzuki, Takashi, Sasano, Hironobu, Andersson, Stefan, Mason, J. Ian · 2000 · The Journal of Clinical Endocrinology & Metabolism
Cited by 31

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

The type 2 isoform of human 17β-hydroxysteroid dehydrogenase (17βHSD2) efficiently catalyzes the oxidative metabolism of androgens and estrogens, and it is expressed in a large series of human peripheral tissues. To obtain a better understanding of the regulation of local steroid biosynthesis and metabolism in human tissues, we have established a dual steroidogenic activity of the 17βHSD2 enzyme after transfection of human 17βHSD2-transfected human embryonic kidney (293) cells. After transient transfection, the metabolism of testosterone, pregnenolone, and dehydroepiandrosterone (DHEA) in intact transfected 293 cells was evaluated by TLC-based radiometric assays. 17βHSD2-transfected cells converted 91% of testosterone (1 μmol/L) into androstenedione in a 2-h incubation period. In addition, pregnenolone (1 μmol/L) was converted to progesterone (18.5%), whereas DHEA (1 μmol/L) was metabolized to androstenedione (8.3% conversion) in a 15-h incubation period. The kinetics of the 3β-hydroxysteroid dehydrogenase (3βHSD) and 17βHSD2 activities using cell homogenate protein of stably transfected 293 cells indicated that the catalytic efficiency (apparent catalytic efficiency = maximum velocity/Km) of this 3βHSD activity is approximately 2000-fold (pregnenolone as substrate) or 3000-fold (DHEA as substrate) weaker than that of 17βHSD2 activity. It is noteworthy, however, that the apparent catalytic efficiency of the HSD3B2 gene product is only approximately 50-fold higher than that of the 3βHSD aspect of the 17βHSD2 gene product. Pregnenolone or DHEA effectively inhibited 17βHSD2 activity in a noncompetitive fashion. Furthermore, the potent 5α-reductase/3βHSD inhibitor, 17β-N,N-diethylcarbamoyl-4-methyl-4-aza-5α-androstane-3-one, inhibited neither 3βHSD nor 17βHSD2 activities. We conclude that human 17βHSD2 enzyme exhibits 3βHSD activity. Notwithstanding that this 3βHSD activity is reduced compared to 17βHSD oxidative activity, it may account for at least some of the reports of 3βHSD activity found in human peripheral tissues that express notable amounts of the 17βHSD2 isozyme as well as in individuals with severe classic 3βHSD deficiency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.85.10.6918

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 31

Metadata

Authors
Suzuki, T., Sasano, H., Andersson, S., & Mason, J. I.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2000-10-01
Volume
85
Issue
10
Pages
3669-3672
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2148088613
Cited by
31
References
11
FWCI
0.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.